πŸ‡ΊπŸ‡Έ FDA
Patent

US 8178534

cMET inhibitors

granted A61PA61P11/00A61P35/00

Quick answer

US patent 8178534 (cMET inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61P, A61P11/00, A61P35/00, A61P35/04, A61P43/00